Matthew M Hutmacher Selected Research

N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamide

12/2012

Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew M Hutmacher Research Topics

Disease

3	Rheumatoid Arthritis 12/2016 - 04/2011
2	Dizziness (Lightheadedness) 01/2016 - 12/2009
1	Necrosis 12/2016
1	Sleepiness 01/2016
1	Fibromyalgia (Fibrositis) 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Pain (Aches) 01/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2016
1	Postherpetic Neuralgia 01/2016
1	Lymphoma (Lymphomas) 09/2015
1	Multiple Myeloma 09/2015
1	Neoplasms (Cancer) 09/2015
1	Body Weight (Weight, Body) 01/2015
1	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 01/2015
1	Renal Insufficiency (Renal Failure) 01/2015
1	Macular Edema 01/2015
1	Seizures (Absence Seizure) 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 07/2014
1	Inflammation (Inflammations) 07/2014
1	Cognitive Dysfunction 01/2014
1	Heart Failure 04/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2012
1	Mental Disorders (Mental Disorder) 12/2011
1	Anxiety Disorders (Anxiety Disorder) 12/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2007

Drug/Important Bio-Agent (IBA)

2	Pregabalin (Lyrica)FDA Link 01/2016 - 12/2009
1	Methotrexate (Mexate)FDA LinkGeneric 12/2016
1	Biosimilar PharmaceuticalsIBA 12/2016
1	Rituximab (Mabthera)FDA Link 12/2016
1	mirogabalinIBA 01/2016
1	LigandsIBA 01/2016
1	Proteasome InhibitorsIBA 09/2015
1	ixazomibIBA 09/2015
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2015
1	pegaptanib (Macugen)FDA Link 01/2015
1	Vigabatrin FDA Link 01/2015
1	4-Aminobutyrate Transaminase (4 Aminobutyrate Transaminase)IBA 01/2015
1	C-Reactive ProteinIBA 07/2014
1	tofacitinibIBA 07/2014
1	CreatinineIBA 07/2014
1	rolofyllineIBA 04/2013
1	Adenosine A1 ReceptorIBA 04/2013
1	N- ((4'- hydroxybiphenyl- 3- yl)methyl)- 2- (3- (2- ((- 2- hydroxy- 2- (4- hydroxy- 3- ((methylsulfonyl)amino)phenyl)ethyl)amino)- 2- methylpropyl)phenyl)acetamideIBA 12/2012
1	Salmeterol Xinafoate (Serevent)FDA Link 12/2012
1	AcidsIBA 12/2011
1	AMPA Receptors (AMPA Receptor)IBA 12/2011
1	Org 26576IBA 12/2011
1	ametantrone (HAQ)IBA 04/2011
1	ElementsIBA 12/2009
1	Etanercept (Enbrel)FDA Link 02/2007

Therapy/Procedure

2	Therapeutics 12/2016 - 01/2015
1	Duration of Therapy 01/2014
1	Phototherapy (Light Therapy) 02/2007